DR Horton Is Maintained at Overweight by Wells Fargo
D.R. Horton Analyst Ratings
Wells Fargo Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $175
Argus Adjusts Price Target on D.R. Horton to $190 From $200
Evercore Maintains D.R. Horton(DHI.US) With Buy Rating, Raises Target Price to $212
DR Horton (DHI) Gets a Buy From Evercore ISI
BofA Securities Maintains D.R. Horton(DHI.US) With Buy Rating, Announces Target Price $290
D.R. Horton Upgraded to Buy From Neutral at BofA
JP Morgan Downgrades D.R. Horton to Underweight, Lowers Price Target to $156
D.R. Horton Analyst Ratings
Oppenheimer Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Barclays Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $170
KBW Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $183
D.R. Horton Downgraded to Market Perform From Outperform at Keefe Bruyette
Seaport Global Maintains D.R. Horton(DHI.US) With Hold Rating
Seaport Global Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Raymond James Downgrades D.R. Horton(DHI.US) to Hold Rating
Erste Group Initiates D.R. Horton(DHI.US) With Hold Rating